Muscle Complaints or Events in Patients Randomized to Simvastatin or Ezetimibe/Simvastatin

Muscle-related events, including less severe muscle complaints without a clear pharmacological relationship to the treatment, may hamper compliance with lipid-lowering therapy and increase the risk of drug discontinuation ([1][1]). In IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy